Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 19.64 billion as of March 18, 2026. Its market cap has increased by 0.08% in one year.

Market Cap

19.64B

Enterprise Value

19.49B

Revenue

2.40B

Ranking

n/a

PE Ratio

398.82

Stock Price

12.28

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 19.64B, an increase of 44.04%. That is a compound annual growth rate of 2.41%.

Market Cap History

Date	Market Cap	% Change
Mar 16, 2026	19.64B	12.56%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jilin Aodong Pharmaceutical Group	21.88B
Tasly Pharmaceutical Group	21.36B
Apeloa Pharmaceutical Co.,Ltd	20.95B
Joincare Pharmaceutical Group Industry	20.69B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	20.29B
Wedge Industrial	19.16B
China Resources Double-Crane Pharmaceutical	18.83B
Betta Pharmaceuticals	18.36B

Market Cap Rankings